Evaluating Biopharma

Preview: Bo Wiinberg on Bridging Research and Trials with Cell-Based Therapies

Are cell therapies the key to bridging the gap between discovery research and clinical trials? In the inaugural episode of the Bioprocessing Unfiltered podcast, Bo Wiinbe

Episode: 23 - An Industry Veteran’s Insight on Data Governance and Provenance

In this episode of Evaluating Biopharma, host Ben Locwin and Scott Endicott, executive leader of Healthcare Solutions Integration, talk about data governance and data pro

Episode: 22 - Insider’s Advice for Starting, Growing, Exiting a Biotech

In this month’s episode of Evaluating Biopharma, host Ben Locwin and Chris Major, founder and partner of BioProcess360 Partners, discuss the best ways to start a company

Episode: 21 - How AI is Changing the Antibody R&D Game

In this month’s episode of Evaluating Biopharma, host Ben Locwin and Tony Arulanandam, SVP and head of R&D at Cytovia Therapeutics, discuss how AI is impacting the antibo

Episode: 20 - Optimal Talent Management in Biopharma with Mara Strandlund and Niamh Alix

In this month’s special episode of Evaluating Biopharma, host Ben Locwin interviews Mara Strandlund, chief people officer at National Resilience, and Niamh Alix, chief hu

Episode: 19 - The Critical Role of Starting Materials & Processes in Advanced Therapies

In this month’s episode of Evaluating Biopharma, host Ben Locwin and Joaquim Vives, head of production of advanced therapies at Banc de Sang i Teixits, discuss cell and g

Episode: 18 - Bispecific Antibodies: What Are They? How Do They Work? An Expert's Thoughts

In this episode of Evaluating Biopharma, host Ben Locwin speaks with Dr. Stefan Schmidt, CEO of evitria AG, about bispecific antibodies. Dr. Schmidt goes into detail abou

Episode: 17 - Essential Program Management Considerations for Biopharma With Jamie Martin

In this episode of Evaluating Biopharma, host Ben Locwin and Jamie Martin, PMP, senior consultant at Black Diamond Networks, discuss the tips and tricks of successful pro

Episode: 16 - Brian Tham on Project Management and Continuous Improvement in Biopharma

In this episode of Evaluating Biopharma, host Ben Locwin speaks with Brian Tham, principal consultant at Peregrine Bio, LLC, on how various projects are run in the pharma

Episode: 15 - Facing CMC Challenges in CDMO-Sponsor Relationships for Rare Disease Platforms with Nesredin Mussa

In this month’s episode of Evaluating Biopharma, host Ben Locwin speaks with Nesredin Mussa, PhD, president of Dynamica Biologics, about navigating the challenges of secu

Episode: 14 - Strategies and Approaches for Process Intensification With Dr. Stefan Schmidt

rocess intensification can be an overwhelming experience. In this episode of Evaluating Biopharma, host Ben Locwin speaks with Dr. Stefan Schmidt, CEO of evitria AG, abou

Episode: 13 - Identifying Impurities In Gene Therapy With Santoshkumar Khatwani

In this episode of Evaluating Biopharma, host Ben Locwin speaks with Santoshkumar Khatwani, Director – Analytical Development, Late-Stage CMC Analytical Team Lead at Sang

Episode: 12 - The Risks and Rewards of Speed-to-IND Strategies With Susan Jones

What are some strategies that companies can use to get to IND filing quickly? In this brand new conversation, Evaluating Biopharma podcast host Ben Locwin discusses the r

Episode: 11 - Cell Therapy Strategies: Preparing for Commercial Manufacturing of an Autologous Cell Therapy

In this episode of Evaluating Biopharma, host Ben Locwin, Vice President of Project Solutions at Black Diamond Networks, speaks with Jonathan Tsang, Senior Director, Manu

Episode: 10 - Gene Therapy Analytics: How to Make the Right CMC Investments for Your Business

In this episode of Evaluating Biopharma, Mike Kelly, Senior Vice President at Atsena Therapeutics, shares his experiences and provides his advice on how your company can

Episode: 9 - Gene Therapy Analytics: Identifying and Overcoming CMC Challenges in Gene Therapy

In this episode of Evaluating Biopharma, Ben Locwin, Vice President of Project Solutions at Black Diamond Networks, speaks with Susan D'Costa, Chief Technology Offic

Episode: 8 - The Financial Impact of a Continuous Bioprocessing Strategy

Joseph Shultz, VP and technical head of biologics and vaccines at Resilience, and John Bonham-Carter, board member and VP of business development and product management a

Episode: 7 - Implementing an Efficient Allogeneic Cell Therapy Manufacturing Strategy

Marty Giedlin, vice president and head of technology operations at Senti Bio, speaks with moderator Ben Locwin, vice president of project solutions at Black Diamond Netwo

Episode: 06 - Process Intensification: PAT, AI, ML to Support Intensified Bioprocessing

Arthi Narayanan, innovation team leader of pharma technical operations at Genentech, and John Bonham-Carter, board member and VP of business development and product manag

Episode: 05 - Navigating Scale-Up Challenges in Protein Production

Parrish Galliher, an independent bioprocess consultant, speaks with moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, about the context